Human monoclonal antibodies targeting subdominant meningococcal antigens confer cross-protection against gonococcus.
Troisi M, Fabbrini M, Stazzoni S, Viviani V, Carboni F, Abbiento V, Fontana LE, Tomei S, Audagnotto M, Santini L, Spagnuolo A, Antonelli G, Paciello I, Vacca F, Cardamone D, Marini E, Mokhtary P, Finetti F, Giusti F, Bodini M, Torricelli G, Limongi C, Del Vecchio M, Favaron S, Tavarini S, Sammicheli C, Rossi A, Mandelli AP, Fortini P, Caffarelli C, Gonnelli S, Nuti R, Efron A, Baldari CT, Sala C, Tagliabue A, Savino S, Brunelli B, Norais N, Frigimelica E, Bardelli M, Pizza M, Margarit I, Delany I, Finco O, Andreano E, Rappuoli R.
Troisi M, et al. Among authors: mandelli ap.
Sci Transl Med. 2025 May 21;17(799):eadv0969. doi: 10.1126/scitranslmed.adv0969. Epub 2025 May 21.
Sci Transl Med. 2025.
PMID: 40397716